![]() |
![]() |
|
OVERVIEW |
OVERVIEW The workshop program will cover the latest advances in the application of MR to cancer research, and will feature invited presentations by scientists from the field of clinical oncology and radiology, as well as from experimental radiology and cancer imaging. In addition to invited scientific presentations, the program will include presentations of proffered papers, poster sessions, and the Negendank Memorial Lecture on a special topic of clinical relevance. AUDIENCE DESCRIPTION This workshop is designed for: · Basic researchers in laboratories using in vivo MRS/MRI or other MR methods in drug development, cancer research, molecular imaging, at the level of faculty, post-doctoral fellows, and graduate students; · Clinical investigators and clinicians in radiology, oncology, or pharmacology; and · Industry scientists employing MR imaging and spectroscopy in the pharmaceutical industry or contrast agent/molecular imaging companies. Members of the audience would have particular interests in methodological development of in vivo MRS and MRI, including applications of MRS and MRI to basic cancer research, clinical translation of MRS and MRI, applications to drug development, and contrast agent development. EDUCATIONAL OBJECTIVES Upon completion of this workshop, participants should be able to: 1. Describe the metabolic role and origin of lipid and phospholipid signals arising from the tumour cell; 2. Assess the role of MR in evaluating cancer stem cells; 3. List five independent MR assessments of the tumour microenvironment; 4. Describe two MR approaches to evaluating invasion and metastasis; 5. Critique targeted contrast media for molecular MR Imaging in Cancer; 6. List five important 13C MR resonances detectable from tumours and describe their importance in cancer; 7. Compare several newly emerging cancer MR biomarkers; 8. Assess the qualification status of three established cancer MR biomarkers; 9. Describe the uses of whole body DWI screening; and 10. Present high-dimensional MR information so clinicians can make best use of it. |
|
The International
Society for Magnetic Resonance in Medicine is accredited |